-
-
-
-
-
-
-
Cocrystal Pharma, Inc. (COCP) Misses Q1 EPS by 23c
-
-
-
-
-
-
-
Cocrystal Pharma Reports First Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
-
-
-
-
-
-
-
Cocrystal Pharma Reports 2022 Financial Results and Provides Updates on its Antiviral Drug Development Programs
-
-
-
-
-
-
-
Cocrystal Pharma, Inc. (COCP) Reports Q1, Provides Updates on its Antiviral Development Programs and Milestones
-
-
-
-
-
-
-
Cocrystal Pharma Reports Second Quarter 2021 Financial Results and Provides Antiviral Program and Milestone Updates
-
-
-
-
-
-
-
Cocrystal Pharma Reports Second Quarter 2020 Financial Results and Provides Updates on Antiviral Programs
-
-
-
-
-
-
-
Detailed Research: Economic Perspectives on Cocrystal Pharma, Genius Brands International, Gemphire Therapeutics, Global Water Resources, Infrastructure and Energy Alternatives, and Condor Hospitality
-
1,200,102 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

